Medical Device Preclinical Testing Services Overview

0

Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) — The “Preclinical Medical Device Testing Services Market Size, Share and Trend Analysis Report by Service (Biocompatibility Testing, Chemistry Testing, microbiology and sterility, packaging validation), by region, and The “Industry Forecast, 2022-2030” report has been added to from ResearchAndMarkets.com offer.

The global preclinical medical device testing services market share is expected to reach $4.9 billion by 2030, according to this report. The increasing incidence of diseases has provided manufacturers with different approaches for the formation of medical devices and the growing demand for technologically advanced medical devices are the major factors driving the growth of the market.

The pace of technological advancement in the healthcare industry has increased dramatically in recent years. Advances in medical device technology allow simple and painless treatment during disease management. Additionally, advancements in medical device technology enable accurate and timely diagnostic results of diseases, as well as affordability of technology-based therapeutic tools for the treatment of diseases. Also, many government agencies and health institutions support medical research facilities. This funding is primarily intended to promote global healthcare innovations. Growth in medical device testing over the forecast period is therefore supported by expanding innovation and technological advancements.

Preclinical testing plays a crucial role in the process of creating new products. Before human testing begins, most of this testing is complete and reports should be available. According to ISO-10993, biocompatibility test results must be included in 510(k) notifications for Class II equipment that is in immediate contact with the patient or with the blood supply. This shows that the risks of the new device are “substantially equivalent” to the risks of the predicate device. In order to show the usefulness of the new device, validate electrical safety or examine electromagnetic interference, testing also involves animal and bench studies.

COVID-19 has created a huge demand for these services. Growth was not significant in the first half, but became more significant in the second as the industry embraced the new standards at a faster pace amid the pandemic. Many projects paused due to COVID have been restarted and PPE kits are seeing increased production and testing. During the pandemic, many high-demand medical devices have diverted attention away from equipment needed for surgery. COVID-19 vaccines, ventilators and pulse oximeters are the main products that have seen a spike in demand.

Highlights of the Preclinical Medical Device Testing Services Market Report

  • The microbiology and sterility testing segment led the market with a revenue share of 34.2% in 2021. It is one of the major tests included in the preclinical testing of medical devices. These examinations help identify the presence of microorganisms in the device.
  • Based on type of microbiology and sterility testing, sterility testing and validation led the market with a revenue share of 45.6% in 2021
  • The chemistry testing segment is expected to post the fastest CAGR of 9.0%. The test is performed in order to categorize, recognize and understand the chemicals used in the production of medical devices
  • Asia-Pacific led the global market in 2021 and is expected to witness the fastest CAGR of 9.0% over the forecast years owing to the low cost of outsourcing medical device testing services

Main topics covered:

Chapter 1. Methodology and scope

Chapter 2. Executive Summary

Chapter 3. Preclinical Medical Device Testing Services Market Variables, Trends and Scope
3.1. Market Line Prospects
3.1.1. Parent Market Outlook
3.1.2. Related/auxiliary market prospects
3.2. Mapping of penetration and growth prospects
3.3. Market dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Complexity in product design
3.3.1.2. Strict approval standards
3.3.1.3. Increase in the number of small medical devices without in-house testing capabilities
3.3.2. Analysis of market constraints
3.3.2.1. Legal and regulatory issues
3.3.3. Mapping of penetration and growth prospects
3.3.4. COVID impact analysis
3.3.5. Analysis of major transactions and strategic alliances
3.3.6. Industry Analysis – Porter’s Five Forces Analysis
3.3.7. Pestle analysis

Chapter 4. Preclinical Medical Device Testing Services Market: Service Segment Analysis
4.1. Preclinical Medical Device Testing Services Market: Definition and Scope
4.2. Preclinical Medical Device Testing Services Market: Services Market Share Analysis, 2021 & 2030
4.3. Biocompatibility tests
4.3.1. Biocompatibility Testing Market, 2018-2030 (USD Million)
4.4. chemistry test
4.4.1. Chemistry Testing Market, 2018-2030 (USD Million)
4.5. Microbiology and sterility tests
4.5.1. Microbiology and Sterility Testing Market, 2018-2030 (USD Million)
4.5.2. Determination of the microbial load
4.5.2.1. Bioburden Determination Market, 2018-2030 (USD Million)
4.5.3. Pyrogen and endotoxin analysis
4.5.3.1. Pyrogen and Endotoxin Testing Market, 2018-2030 (USD Million)
4.5.4. Sterility testing and validation
4.5.4.1. Sterility Testing and Validation Market, 2018-2030 (USD Million)
4.5.4.2. Ethylene Oxide (EO) Gas Sterilization
4.5.4.2.1. Ethylene Oxide (EO) Gas Sterilization Market, 2018-2030 (USD Million)
4.5.4.3. Gamma radiation
4.5.4.3.1. Gamma Irradiation Market, 2018-2030 (USD Million)
4.5.4.4. Electron beam sterilization
4.5.4.4.1. Electron Beam Sterilization Market, 2018-2030 (USD Million)
4.5.4.5. X-ray sterilization
4.5.4.5.1. X-Ray Sterilization Market, 2018-2030 (USD Million)
4.5.5. Antimicrobial activity test
4.5.5.1. Antimicrobial Activity Testing Market, 2018-2030 (USD Million)
4.5.6. Others
4.5.6.1. Others Market, 2018 – 2030 (USD Million)
4.6. Packaging validation
4.6.1. Packaging Validation Market, 2018-2030 (USD Million)

Chapter 5. Preclinical Medical Device Testing Services Market: Regional Analysis

Chapter 6. Competitive Landscape
6.1. Company Profiles
6.1.1. SGS S.A.,
6.1.1.1. Company presentation
6.1.1.2. Financial performance
6.1.1.3. Benchmarking Services
6.1.1.4. Strategic initiatives
6.1.2. LabCorp
6.1.2.1. Company presentation
6.1.2.2. Financial performance
6.1.2.3. Benchmarking Services
6.1.2.4. Strategic initiatives
6.1.3. Eurofins Scientific
6.1.3.1. Company presentation
6.1.3.2. Financial performance
6.1.3.3. Benchmarking Services
6.1.3.4. Strategic initiatives
6.1.4. Pace Analytical Services LLC
6.1.4.1. Company presentation
6.1.4.2. Financial performance
6.1.4.3. Benchmarking Services
6.1.4.4. Strategic initiatives
6.1.5. PLC of the Intertek group
6.1.5.1. Company presentation
6.1.5.2. Financial performance
6.1.5.3. Benchmarking Services
6.1.5.4. Strategic initiatives
6.1.6. Wuxi AppTec
6.1.6.1. Company presentation
6.1.6.2. Financial performance
6.1.6.3. Benchmarking Services
6.1.6.4. Strategic initiatives
6.1.7. Tuv South AG
6.1.7.1. Company presentation
6.1.7.2. Financial performance
6.1.7.3. Benchmarking Services
6.1.7.4. Strategic initiatives
6.1.8. Sterigenics International LLC
6.1.8.1. Company presentation
6.1.8.2. Financial performance
6.1.8.3. Benchmarking Services
6.1.8.4. Strategic initiatives
6.1.9. Nelson Laboratories
6.1.9.1. Company presentation
6.1.9.2. Financial performance
6.1.9.3. Benchmarking Services
6.1.9.4. Strategic initiatives
6.1.10. North American Science Associates, Inc.
6.1.10.1. Company presentation
6.1.10.2. Financial performance
6.1.10.3. Benchmarking Services
6.1.10.4. Strategic initiatives
6.1.11. Charles River International Laboratories, Inc.
6.1.11.1. Company presentation
6.1.11.2. Financial performance
6.1.11.3. Benchmarking Services
6.1.11.4. Strategic initiatives

For more information about this report visit https://www.researchandmarkets.com/r/85vz08

  • Global Preclinical Medical Device Testing Services Market


        
Share.

About Author

Comments are closed.